Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-10-21 00:00:00 ET · period of report 2022-10-19 · accession 0000899243-22-033945 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-21 | 2022-10-19+ | BDTX | BB BIOTECH AG | 10% | P - Purchase | $1.36 | +131.4K | 4.83M | +3% | +$178.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-19 | P | A | 77,689 | $1.32 | 4,771,802 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-20 | P | A | 53,734 | $1.42 | 4,825,536 | D | — | — |